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Introduction
The success of magnetic resonance imaging (MRI) as a clini-
cal diagnostic technique is largely related to the use of para-
magnetic contrast agents, which improve the contrast be-
tween normal and diseased tissues. Trivalent gadolinium
chelates have proven to be the most suitable MRI contrast
agents (CAs).[1–7] One of the big challenges in the develop-
ment of new CAs is the improvement of their relaxivity and
their capability to target certain organs and tissues, which
Abstract: We report the synthesis and
characterization of the novel ligand
H5EPTPA-C16 ((hydroxymethylhexade-
canoyl ester)ethylenepropylenetriami-
nepentaacetic acid). This ligand was
designed to chelate the GdIII ion in a
kinetically and thermodynamically
stable way while ensuring an increased
water exchange rate (kex) on the Gd
III
complex owing to steric compression
around the water-binding site. The at-
tachment of a palmitic ester unit to the
pendant hydroxymethyl group on the
ethylenediamine bridge yields an am-
phiphilic conjugate that forms micelles
with a long tumbling time (tR) in aque-
ous solution. The critical micelle con-
centration (cmc = 0.34 mm) of the am-
phiphilic [Gd(eptpa-C16)(H2O)]
2 che-
late was determined by variable-con-
centration proton relaxivity measure-
ments. A global analysis of the data
obtained in variable-temperature and
multiple-field 17O NMR and 1H
NMRD measurements allowed for the
determination of parameters governing
relaxivity for [Gd(eptpa-C16)(H2O)]
2 ;
this is the first time that paramagnetic
micelles with optimized water ex-
change have been investigated. The
water exchange rate was found to be
k 298ex = 1.7<10
8 s1, very similar to that
previously reported for the nitrobenzyl
derivative [Gd(eptpa-bz-NO2)(H2O)]
2
(k 298ex = 1.5<10
8 s1). The rotational dy-
namics of the micelles were analysed
by using the Lipari–Szabo approach.
The micelles formed in aqueous solu-
tion show considerable flexibility, with
a local rotational correlation time of
t 298l0 = 330 ps for the Gd
III segments,
which is much shorter than the global
rotational correlation time of the
supramolecular aggregates, t298g0 =
2100 ps. This internal flexibility of the
micelles is responsible for the limited
increase of the proton relaxivity ob-
served on micelle formation (r1 =
22.59 mm1 s1 for the micelles versus
9.11 mm1 s1 for the monomer chelate
(20 MHz; 25 8C)).
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(transverse relaxation rate enhancement, proton relaxivities, and vari-
able-temperature reduced transverse and longitudinal 17O relaxation
rates and chemical shifts for selected solutions.
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would allow the clinical use of lower doses[8,9] (proton relax-
ivity is defined as the paramagnetic longitudinal proton re-
laxation rate enhancement due to one millimolar concentra-
tion of the agent). Theory predicts that slow rotation of the
chelates in solution (long tR values) and fast water exchange
between the ion coordination sphere and the bulk water
(high kex = 1/tm values, where tm is the lifetime of the water
molecule in the coordination sphere) will lead to higher re-
laxivities.[4,6] Upon attachment of low molecular weight GdIII
chelates to macromolecules, the rotation slows down and
the relaxivity increases. However, this increase is usually far
from optimal (r1max~100 mm1 s1 for a q = 1 complex at
20–60 MHz proton Larmor frequency) because either the
bound chelate is too flexible (internal motions dominate) or
water exchange becomes limiting (tm>T1M).
[2,6]
Several approaches have been attempted to increase tR
values in the search for high relaxivities. These involved the
formation of covalent or noncovalent conjugates between
the paramagnetic chelate and slowly moving substrates
(dendrimers,[10] proteins,[11] carbohydrates[12]). An appealing
alternative way to increase tR is through self-assembly of
amphiphilic GdIII chelates to form micelles.[13] Many of these
GdIII-containing assemblies behave as colloidal carriers
which, in addition to the increased relaxivities, have good
pharmacological characteristics.[14] They can be efficiently
taken up by macrophage-rich tissue undergoing endocytosis/
phagocytosis (liver and spleen),[15,16] and have proved to be
useful for diagnostic purposes.[15] Long-circulating colloidal
systems with entrapped radiopharmaceuticals or CAs have
been successful in blood-pool imaging.[17–19]
Several GdIII based micellar systems have been designed
and characterized.[13,20 ,21] In these systems the relaxivities
were considerably improved owing to the longer tumbling
times in solution but low water exchange rates seriously cut
back the relaxivity gain.
The chelate [Gd(trita)(H2O)]
 (H4TRITA = 1,4,7,10-tet-
raazacyclotridecane-N,N’,N’’,N’’’-tetraacetic acid) was re-
ported to have fast water exchange resulting from steric
compression around the water-binding site. The increased
steric crowding in this chelate is achieved by replacing an
ethylene bridge of DOTA4 (H4DOTA = 1,4,7,10-tetraaza-
cyclododecane-N,N’,N’’,N’’’-tetraacetic acid) with a propyl-
ene bridge.[22] The same strategy proved successful in accel-
erating water exchange in the GdIII chelates of modified
DTPA5 ligands (H5DTPA = diethylenetriamine-
N,N,N’,N’’,N’’-pentaacetic acid). These ligands present one
propylene bridge (H5EPTPA = ethylenepropylenetriamine-
N,N,N’,N’’,N’’-pentaacetic acid) instead of the original ethyl-
ene bridge, or one coordinating propionate arm (H5DTTA-
N’-prop = diethylenetriamine-N,N,N’’,N’’-tetraacetic-N’-pro-
pionic acid) instead of the acetate arm of DTPA5.[23] A dif-
ferent system displaying fast water exchange at the GdIII ion
is based on a monoamide DOTA complex, as demonstrated
by Parker and co-workers.[24]
With the objective of slowing down the rotation, the fast
exchanging [Gd(eptpa)(H2O)]
2 chelate was attached to dif-
ferent generations (5,7, and 9) of PAMAM dendrimers.[25] A
combined 17O NMR and proton relaxivity study of these sys-
tems showed that, in contrast to previously reported dendri-
meric GdIII complexes, the proton relaxivity was indeed not
at all limited by slow water exchange.
In this paper we report the synthesis of the new ligand
H5EPTPA-C16 ((hydroxymethylhexadecanoyl ester)ethylene-
propylenetriaminepentaacetic acid)), which was designed to
chelate the GdIII ion in a kinetically and thermodynamically
stable way[23] while simultaneously optimizing the rotational
correlation time and the water exchange rate to result in a
higher relaxivity. The tumbling time of the chelate is slowed
down upon attachment of a C16 lipophilic chain to the
-CH2OH pendant group through ester bond formation. Be-
cause of the capability of this amphiphilic species to form
micelles in solution, its tR value will be substantially in-
creased. In addition, the tm value of the Gd
III chelate is opti-
mized in comparison with commercial chelates such as [Gd-
(dtpa)(H2O)]
2, as a consequence of increased steric com-
pression in the coordination sphere of the metal ion, which
is brought about by the propylene bridge that connects the
two nitrogen atoms.
The critical micelle concentration (cmc) of the amphiphil-
ic [Gd(eptpa-C16)(H2O)]
2 chelate was determined by
proton relaxivity measurements. With the aim of assessing
the parameters that determine proton relaxivity, the water
exchange rate and rotational correlation time in particular,
we carried out a variable-temperature and multiple-field 17O
NMR and 1H NMRD study. The rotational dynamics of the
micelles was described in terms of local and global motions,
related to motions of the GdIII segments and of the entire
micelle, respectively, by using the Lipari–Szabo approach in
the analysis of longitudinal NMR relaxation rates.
Results and Discussion
Synthesis : The new CA skeleton EPTPA5 was proposed re-
cently.[23] It features a masked, pendant amine group on the
ethylenediamine unit designed for conjugation to chemical
moieties for targeting purposes and for the formation of
macromolecular complexes. In this paper we report a new
synthetic route to the EPTPA5 skeleton bearing a hydroxy-
methyl group on the ethylenediamine unit (Scheme 1).
We envisaged that coupling a fatty acid to the hydroxy-
methyl group would generate the amphiphilic molecule 8
(eptpa-C16), which would self-assemble in solution, increas-
ing the tumbling time and the relaxivity of its GdIII complex.
The reductive amination of the Garner aldehyde 2 with
the Boc-monoprotected diamine 3 is the key reaction in the
construction of the EPTPA scaffold. The reducing agent
sodium triacetoxyborohydride NaBH(OAc)3 proved to be
highly efficient.[26] The Garner aldehyde 2 was obtained by a
high-yielding, three-step procedure from serine methyl ester
hydrochloride 1.[27] The fully protected triamine 4 was de-
protected in quantitative yield in one step with a HCl 6m/
EtOH (1:1) mixture. The alkylation reaction required preti-
tration of the aqueous triamine hydrochloride to neutral
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pH. Titration with Dowex 1X2-100-OH resin proved to be
a convenient procedure. The fully deprotected triamine 5
was of analytical purity and was carried through without fur-
ther purification. Triamine 5 was alkylated with tBu-bro-
moacetate in a standard procedure.[23] The fully alkylated
material 6 was coupled to palmitic acid through the anhy-
dride method. The resulting ester 7 was isolated as an
adduct with an extra molecule of palmitic acid, as demon-
strated by 1H NMR spectroscopy. No attempts were made
to purify the compound at this stage. We reasoned that it
would be more efficient to carry this material through and
to perform the final purification on the material at the fully
deprotected stage. The deprotection with TFA/CH2Cl2 pro-
ceeded uneventfully, affording the deprotected material as
an adduct with an extra molecule of palmitic acid. The pal-
mitic acid adduct was suspended in water and titrated to
neutrality with aqueous KOH. This procedure allowed the
removal of the insoluble potassium palmitate by filtration.
The final compound was purified by RP C8 chromatography
eluting with H2O/EtOH (100% H2O!100% EtOH) to
afford the title material 8 in analytical purity.
The hydroxymethyl group on the ethylenediamine unit
originates from the amino acid serine. The synthesis started
with the unnatural R enantiomer. This synthetic route is not
likely to have led to racemization or inversion of configura-
tion on the stereogenic centre. Optical rotation measure-
ments indicate that our final compound is optically active.
Further studies are needed in order to confirm the absolute
stereochemistry and the enantiomeric purity of the final
compound 8.
Determination of the critical
micellar concentration (cmc):
The amphiphilic GdIII chelate is
expected to behave as a surfac-
tant in aqueous solution, that is,
to form macromolecular micel-
lar structures. Micelle formation
is characterized by the critical
micellar concentration (cmc),
the lowest concentration limit
at which micelles start to
appear in solution. We have de-
termined the cmc value by
means of 1H relaxivity measure-
ments (60 MHz and 25 8C). This
procedure, previously establish-
ed for paramagnetic micellar
systems, is based on the varia-
tion of the water 1H longitudi-
nal relaxation rate with increas-
ing concentrations of the GdIII
chelate.[21] The measurements
are performed at a frequency at
which the relaxivity is principal-
ly determined by rotation. Ac-
cordingly, micelle formation
will result in slower molecular
tumbling and a concomitant increase of the observed proton
relaxivity. At concentrations lower than the cmc no aggre-
gates form, and under these conditions, only the monomeric
chelate contributes to the paramagnetic 1H relaxation rate
measured in the solution, which is given by Equation (1), in
which Rd1 is the diamagnetic contribution to the longitudinal
relaxation rate (the relaxation rate of pure water), rn:a1 repre-
sents the relaxivity of the free, nonaggregated GdIII chelate
(in mmol1 s1), and cGd is the analytical Gd
III concentration.
Robs1 Rd1 ¼ rn:a1  CGd ð1Þ
At concentrations greater than the cmc, the measured re-
laxation rate is the sum of two contributions, one due to the
chelate as monomer (free surfactant) present at a concentra-
tion given by the cmc, and the other due to the aggregated
form (micelles). The water 1H relaxation rate measured for
the paramagnetic solution can be then expressed as in Equa-
tion (2), in which ra1 is the relaxivity of the micellar (aggre-
gated) form.
Robs1 R a1 ¼ ðr n:a1 r a1Þcmcþra1þcGd ð2Þ
The cmc is determined from the plot of the paramagnetic
relaxation rates versus the GdIII concentration as shown in
Figure 1, based on a simultaneous least-squares fit of the
two straight lines. The slopes of these two lines define r n:a1
and r a1 , below and above the cmc, respectively. The values
obtained were r n:a1 = 7.79 mmol
1 s1 and r a1 =
24.21 mmol1 s1 (at 25 8C and 60 MHz). The cmc was found
Scheme 1. Synthetic route for the hydroxymethyl(EPTA) palmitoyl ester conjugate. a) NaBH(OAc)3/1,2-di-
chloroethane; b) i) HCl (aq. sol. 6m)/EtOH 1:1, ii) titration to pH 7 with Dowex1-X2-100-OH ; c) tBu bro-
moacetate, DIPEA, KI/DMF; d) palmitic anhydride, Py, DMAP/CH2Cl2; e) i) TFA/CH2Cl2 3:1, ii) titration to
pH 7.0 with aq. KOH, iii) RPC8 flash chromatography.
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to be 0.340.02 mm, which, in a comparison to previously
studied, similar amphiphilic GdIII complexes with hydrocar-
bon chains, falls exactly into the range expected for a com-
pound with a sixteen-carbon lipophilic tail (Figure 2).[21]
17O NMR and 1H NMRD measurements : In order to deter-
mine the water exchange rate and assess the rotational dy-
namics of the [Gd(eptpa-C16)(H2O)]
2 chelate, we measured
variable-temperature, transverse and longitudinal 17O relax-
ation rates and chemical shifts at two magnetic fields (4.7
and 9.4 T), at a concentration (0.027 molkg1) that well ex-
ceeds the cmc (see also Supporting Information). We thus
consider that the contribution of the monomeric form to the
17O experimental data is negligible. Additionally, proton re-
laxivities were measured as a function of the Larmor fre-
quency (NMRD profiles) at three different temperatures
and EPR spectra were also recorded. Based on the analogy
to the previously reported [GdIII(eptpa-bz-NO2)(H2O)]
2,
we assume [GdIII(eptpa-C16)(H2O)]
2 to be nine-coordinate
with one inner-sphere water molecule.[23] For the momomer-
ic form of the chelate, we have determined the field-depen-
dent proton relaxivities, r n:a1 by
1H NMRD measurements at
a concentration of 0.2 mm (below the cmc, Figure 3).
NMRD profiles were also recorded at cGd = 2 mm concen-
tration (above the cmc). The relaxivities of the aggregated
form, r a1 , were calculated at each temperature and magnetic
field (Figure 4c) by subtracting the relaxation rate contribu-
tion of the monomer chelate, present at the concentration of
the cmc (r n:a1 <cmc), from the paramagnetic relaxation rate
values measured at cGd = 2 mm (R
obs
1 Rd1), according to
Equation (3).
r a1 ¼ ðR obs1 R d1r n:a1  cmcÞ=ðcGdcmcÞ ð3Þ
For the aggregated form of the chelate, we performed a
simultaneous least-squares fit of the 17O NMR, EPR, and
NMRD data [the latter calculated with Equation (3)]. All
the available experimental data (17O NMR chemical shifts,
Dwr, longitudinal (1/T1r) and transverse (1/T2r) relaxation
rates, longitudinal proton relaxivities (r1), and transverse
electron spin relaxation rates, obtained from the EPR spec-
Figure 1. Variation of the water 1H longitudinal relaxation rate versus the
total GdIII concentration at 60 MHz and 25 8C for [Gd(eptpa-C16)-
(H2O)]
2, and least-squares fit according to Equation (2).
Figure 2. cmc obtained for [Gd(eptpa-C16)(H2O)]
2 is in accordance with the values for previously reported systems.
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tra) were analysed simultaneously. The data were fitted to
the conventional Solomon–Bloembergen–Morgan theory,[7]
except for the description of the rotational dynamics (influ-
encing both 17O and 1H longitudinal relaxation), for which
we used the model-free Lipari–Szabo approach.[28,29] Indeed,
the longitudinal 17O relaxation rates show a distinct magnet-
ic field dependence, which is always a clear indication of
slow molecular motions and cannot be described by the
common spectral density functions applied for small-molec-
ular-weight chelates. According to the Lipari–Szabo ap-
proach, the modulation of the interaction that causes relaxa-
tion is the result of two statistically independent motions: a
rapid local motion of the GdIII segments, with a local rota-
tional correlation time tl, and a slower global motion of the
entire micellar aggregate, with a global rotational correla-
tion time tg. The degree of spatial restriction of the local
motion with regard to the global rotation is given by an ad-
ditional model-free parameter S 2. For a totally free internal
motion S 2 = 0, while for a local motion that is exclusively
correlated to the global motion S 2 = 1.
Given the large number of parameters involved in the
analysis of the 17O NMR, EPR, and NMRD data, some had
to be fixed to common and physically meaningful values.
For the distances we used rGdO = 2.5 R (Gd electron spin to
17O nucleus distance), rGdH = 3.1 R (Gd electron spin to
1H
nucleus distance), and aGdH = 3.5 R (closest approach of
the bulk water protons to the gadolinium). The quadrupolar
coupling constant for the bound water oxygen, c(1+h2/3)
1=2 ,
was fixed to 5.2 MHz.[30] The longitudinal 17O relaxation is
related to motions of the Gd coordinated water oxygen
vector, while the proton relaxation is determined by motions
of the Gd coordinated water proton vector. For the ratio of
the rotational correlation time of the Gd–Hwater and Gd–
Owater vectors tRH/tRO, similar values have been found for
various small molecular weight monohydrated GdIII com-
plexes, both by experimental studies and molecular dynam-
ics (MD) simulations (tRH/tRO = 0.650.2).[30,31] This tRH/
tRO ratio, within the given error, is considered to be a gener-
al value for the ratio of the two rotational correlation times.
Thus, in the simultaneous analysis of 17O NMR and NMRD
data, we fixed the ratio of the local correlation times of the
Gd-coordinated water proton vector (tlH) and the Gd-coor-
dinated water oxygen vector (tlO) to 0.65. The global rota-
tional correlation times obtained from oxygen and proton
relaxation are identical (tgO = tgH). In the analysis, we fitted
the rotational correlation times t 298l0 and t
298
g0 , characterizing
the motion of the Gd–Owater vector. The experimental
NMRD and 17O NMR data and the fitted curves for
Figure 3. 1H nuclear magnetic relaxation dispersion profiles of the mono-
mer form of [Gd(eptpa-C16)(H2O)]
2 (0.2 mm): 5 8C (*), 25 8C (&), and
37 8C (!).
Figure 4. Temperature dependence of a) reduced-transverse and longitu-
dinal 17O relaxation rates 1/T2r and 1/T1r, respectively; B = 9.4 T (ln(1/
T1r): &, (ln(1/T2r): *, and B = 4.7 T (ln(1/T1r): !, (ln(1/T2r): +; b) reduced
chemical shifts Dwr (B = 9.4 T: & and B = 4.7 T: !) of [Gd(eptpa-C16)-
(H2O)]
2 (cGd = 26.77 mmolkg
1); c) 1H nuclear magnetic relaxation dis-
persion profiles of the aggregated form (2 mm), recorded at 5 8C (*),
25 8C (&), and 37 8C (!). The lines represent the least-squares fit of the
data points as explained in the text.
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[GdIII(eptpa-C16)(H2O)]
2 are presented in Figure 4. The X-
band peak-to-peak EPR line widths, not presented in
Figure 4 but included in the fit, were between 440 Gauss
(270 K) and 480 Gauss (316 K). The most relevant parame-
ters obtained in the fit are shown in Table 1. For the elec-
tronic relaxation parameters we obtained the following
values: t 298v = 435 ps and D2 = (0.070.01)<1020 s2; Ev
was fixed to 1.0 kJmol1. The value of the 17O scalar cou-
pling constant, essentially calculated from the 17O chemical
shifts, is A/h1 = (3.10.3)<106 rad s1. The diffusion con-
stant D 298GdH and its activation energy EDGdH were calculated
to be (282)<1010 m2s1 and (251) kJmol1, respective-
ly.
The NMRD profiles measured at three different tempera-
tures for the nonaggregated chelate were also fitted. Here,
the rotational dynamics were described by the common
spectral density functions of the Solomon–Bloembergen–
Morgan theory, since the rotation is not slow enough to re-
quire the Lipari–Szabo treatment. Owing to the lack of 17O
NMR data directly on the monomer form, in the fit of the
NMRD profiles we fixed the water exchange rate and the
activation enthalpy to the values obtained for the micellar
form (Table 1). The electronic parameters calculated are
t 298v = 448 ps and D2 = (0.080.01)<1020 s2 ; Ev was
fixed to 1.0 kJmol1. For the rotational correlation time, we
obtained trH = 20030 ps, which corresponds to a value ex-
pected for a molecule of the given molecular weight
(Table 2). The experimental NMRD profiles and the fitted
curves are presented in Figure 3.
Water exchange rate and rotational dynamics : Table 2 shows
proton relaxivity data, water exchange rates, and rotational
correlation times for a series of GdIII com-
pounds[13,22,23, 25,34,35] compared with the present results for
[Gd(eptpa-C16)(H2O)]
2, both in nonaggregated and aggre-
gated forms. The water exchange rate of [Gd(eptpa-C16)-
(H2O)]
2, k 298ex = 170<10
6 s1, is consistent with the values
obtained for analogous GdIII-eptpa derived chelates. In all
of these compounds, steric compression around the water-
binding site leads to accelerated water exchange in compari-
son with the DTPA-type GdIII complexes. With regard to ro-
tational dynamics, the large difference between the local
(330 ps) and global (2100 ps) rotational correlation time of
the aggregated [Gd(eptpa-C16)(H2O)]
2 shows that the
motion of a GdIII chelate segment (characterized by tl) is
considerably faster than that of the whole micellar assembly
(tg). This, together with the value of the order parameter S
2
= 0.41, is a strong indication of the internal flexibility of the
micelles. The parameter tg, reflecting the global motion of
the [Gd(eptpa-C16)(H2O)]
2 micellar assembly, is of the
same order of magnitude as those reported for amphiphilic
[Gd(dotacn)(H2O)]
 complexes (n = 12, 14, 18),[35] but
much smaller than the values for the large dendrimeric
structures such as Gadomer 17[34] or G5-(Gd-eptpa)115.
[25]
The tl value for the [Gd(eptpa-C16)(H2O)]
2 micelles is also
similar to those for [Gd(dotacn)(H2O)]
 (n = 12, 14, 18),[35]
but shorter than that for Gadomer 17, which has a less flexi-
ble dendrimeric structure. On the other hand, the value of
the order parameter, S 2 = 0.41 for [Gd(eptpa-C16)(H2O)]
 ,
is only slightly smaller than S 2 = 0.5 calculated for Gadom-
er 17.
The interaction of [Gd(eptpa-C16)(H2O)]
 with human
serum albumin (HSA) was tested in a solution containing
4.5% HSA. No increase in proton relaxivity was observed
Table 1. Parameters obtained from the simultaneous fit of 17O NMR,
EPR, and 1H NMRD data for the aggregated form of the [Gd-eptpa-C16-
(H2O)]
2 complex.
Parameter
k298ex
/106 s1 17030
DH/kJmol1 23.61.0
t298g /ps
1 2100200
Eg/kJmol
1 19.31.0
tl/ps 33040
El/kJmol
1 49.02.0
S 2 0.410.08
Table 2. Relaxivity (at 20 MHz and 25 8C) and parameters determining relaxivity for selected GdIII complexes.
k298ex <10
6 [s1] tgO [ps] tlO [ps] S
2 r1 [mm
1 s1]
small molecular weight chelates
[Gd(eptpa-bz-NO2)(H2O)]
2 [23] 150 tRO = 122 – – 4.73
[Gd(eptpa)(H2O)]
2 [23] 330 tRO = 75 – –
[Gd(trita)(H2O)]
 [22] 270 tRO = 82 – –
[Gd(eptpa-C16)(H2O)]
2 [a,b] 170 tRH = 200 – – 9.11
dendrimers
Gadomer 17[34] 1.0 3050 760 0.50 16.46
G5-(Gd-eptpa)115
[25] 150 4040 150 0.43 23.9[c]
micelles
[Gd(dotasa-C12(H2O)]
 [13] 4.8 920 – – 18.03
[Gd(dota-C10)(H2O)]
 [35] 4.8 tRO = 470 – – 9.32
[Gd(dota-C12)(H2O)]
 [35] 4.8 1600 430 0.23 17.24
[Gd(dota-C14)(H2O)]
 [35] 4.8 2220 820 0.17 21.45
[Gd(dotasa-C18)(H2O)]
 [35] 4.8 2810 330 0.28 20.72
[Gd(eptpa-C16)(H2O)]
 [a] 170 2100 330 0.41 22.59
[a] This work. [b] Nonaggregated form. [c] T = 37 8C.
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as compared with a sample without HSA (60 MHz), there-
fore we concluded that there is no significant interaction be-
tween the long chain and serum albumin.
Conclusion
We have devised a new, high-yielding synthetic strategy for
the synthesis of a new chelator with the EPTPA skeleton
featuring a hydroxymethyl group on the ethylenediamine
unit. The hydroxymethyl group is available for direct conju-
gation to a plethora of chemical moieties through different
linkages (ester, ether, phosphodiester, glycosidic bond).
Moreover, the hydroxyl group may be easily converted to
other functional groups such as aldehyde, carboxylic acid, or
azide, leading to other convenient handles for conjugation.
In this paper we have constructed a conjugate with a fatty
acid to illustrate the concept. Furthermore, some linkages
involving oxygen, for example, ester and phosphodiester,
are enzyme-labile, and could potentially lead to smart con-
trast agents.
On the basis of a rational design, we have prepared a new
amphiphilic GdIII chelate, for which the parameters influenc-
ing relaxivity were obtained from a simultaneous analysis of
NMRD, EPR, and 17O NMR data. As a result of micellar
self-assembly in aqueous solution, the chelate has an in-
creased rotational correlation time. In addition, due to a
steric compression in the inner coordination sphere of the
paramagnetic ion, both the amphiphilic monomer and the
supramolecular micellar assembly display close to optimal
water exchange rates, two orders of magnitude superior to
the chelating agents in clinical use. However, the self-assem-
bly of the amphiphilic monomers leads to only a modest in-
crease in relaxivity, as the rotational dynamics are strongly
dominated by fast local motions of the GdIII segments
within the micelle. Clearly, as demonstrated by simulations,
much higher relaxivities are achievable for chelates with
water exchange rates of this order of magnitude, as long as
the local rotational correlation times do not become limit-
ing. The rigidification of the micelles is one possible route
towards substantially higher relaxivities.
The lipophilic tail is attached to the chelate moiety
through an ester bond, which will likely be cleaved in the
presence of lipases. Such transformation of the chelate will
significantly reduce the observed relaxivity. This behaviour
could make the [Gd(eptpa-C16)(H2O)]
2 chelate a respon-
sive contrast agent, sensitive to the presence of lipases. In-
vestigations in this area are in progress and will be reported
in due course.
Experimental Section
Preparation of the complex : The GdIII chelate of EPTPA-C16 was pre-
pared by mixing equimolar amounts of Gd(ClO4)3 and the ligand in a
50 mm TRIS (tris(hydroxymethyl)aminomethane) buffer solution (pH
around 7.0) or in 150 mm MES (2-[N-morpholino]ethanesulfonic acid)
buffer solution (pH around 6.4). A slight excess (5%) of ligand was used.
The absence of free metal was checked through the xylenol orange
test.[32] The Gd(ClO4)3 stock solution was made up by dissolving Gd2O3
in a slight excess of HClO4 (Merck, p.a. 60%) in double-distilled water,
followed by filtering. The pH of the stock solution was adjusted to 5.5 by
addition of Gd2O3 and its concentration was determined by titration with
Na2H2EDTA solution using xylenol orange as an indicator.
Sample preparation : For the critical micellar concentration determination
a 17.02 mm [Gd(eptpa-C16)(H2O)]
2 stock solution in 50 mm TRIS buffer
was prepared. A series of [Gd(eptpa-C16)(H2O)]
2 solutions with differ-
ent concentrations was prepared by diluting the stock solution. For the
NMRD profiles two solutions were prepared from the 17.02 mm stock so-
lution; one below (0.2 mm) and the other above (2 mm) the CMC value
previously determined. For the 17O NMR measurements, a
26.77 mmolkg1 solution enriched to 2% by using 10% 17O-enriched
water (Yeda Co., Rehovot, Israel) was prepared.
Determination of the CMC by 1H relaxivity measurements : The concen-
tration range for this determination was 12510–0.010 mm. For each
sample, longitudinal 1H relaxation rates were measured at 25 8C and
60 MHz (1.41 T) with a WP-60 electromagnet connected to a Bruker AC-
200 console. The temperature was stabilized with a Bruker temperature
control unit by gas flow. The longitudinal relaxation rate, 1/T1, was ob-
tained with the inversion-recovery method.
NMRD measurements : The measurements were performed by using a
Stelar Spinmaster FFC NMR relaxometer (0.01–20 MHz) equipped with
a VTC90 temperature control unit. At higher fields, the 1H relaxivity
measurements were performed on Bruker Minispecs mq30 (30 MHz),
mq40 (40 MHz), and mq60 (60 MHz) and on Bruker 50 MHz (1.18 T),
100 MHz (2.35 T), and 200 MHz (4.70 T) cryomagnets connected to a
Bruker AC-200 console. In each case, the temperature was measured by
a substitution technique. Longitudinal relaxation rates were measured at
two different concentrations, one below (0.2 mm) and the other above
the CMC (2 mm) at 25 8C. Variable-temperature measurements were per-
formed at 5, 25, and 37 8C.
EPR spectroscopy : The spectra were recorded in a conventional Elexsys
spectrometer E500 at X-band (9.4 GHz). A controlled nitrogen gas flow
was used to maintain a constant temperature, which was measured by a
substitution technique. The transverse electronic relaxation rates, 1/T2e,
were calculated from the EPR line widths according to Reuben.[36]
17O NMR spectroscopy : The solution samples were sealed in glass
spheres adapted for 10 mm NMR tubes to avoid susceptibility corrections
of the chemical shift. Transverse and longitudinal 17O relaxation rates
and chemical shifts were measured for temperatures between 1.9 and
52 8C. Temperatures above 60 8C were not used to avoid compound de-
composition. Data were recorded at two different magnetic fields (9.4
and 4.7 T). Acidified water of pH 3.4 was used as an external reference.
Data analysis : The least-squares fits on the 17O NMR and NMRD relaxa-
tion data were performed with the Visualiseur/Optimiseur programs on a
Matlab platform version 5.3.[33]
Materials and equipment : Chemicals were purchased from Sigma-Aldrich
and used without further purification. Solvents used were of reagent
grade and purified by usual methods. Reactions were monitored by TLC
on Kieselgel 60 F254 (Merck) on aluminium support and on silica gel RP-
18 on glass support (Fluka). Detection was by examination under UV
light (254 nm), by adsorption of iodine vapour and spraying with ninhy-
drine. Flash chromatography was performed on Kieselgel 60 (Merck,
mesh 230–400) and on silica gel 100C8-reversed phase (Fluka). The rele-
vant fractions from flash chromatography were pooled and concentrated
under reduced pressure, T < 40 8C. 1H and 13C NMR spectra (assigned
by 2D DQF-COSY and HMQC techniques) were run on a Varian Unity
Plus 300 NMR spectrometer, operating at 299.938 and 75.428 MHz for
1H and 13C, respectively. Chemical shifts (d) are given in ppm relative to
the CDCl3 solvent (
1H, d = 7.27 ppm; 13C 77.36 ppm) as internal stan-
dard. For 1H and 13C NMR spectra recorded in D2O, chemical shifts (d)
are given in ppm relative to TSP as internal reference (1H, d = 0.0 ppm)
and tert-butanol as external reference (13C, CH3 d = 30.29 ppm).
13C
NMR spectra were proton broad-band decoupled using a decoupling
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scheme. Compound 2 (GarnerTs aldehyde) was synthesised by a three-
step procedure according to the literature.[26]
Fully protected triamine 4 : A solution of N-Boc-1,3-propanediamine 3
(1.46 g, 8.37 mmol) and GarnerTs aldehyde 2 (1.83 g, 7.98 mmol) in 1,2-di-
chloroethane (80 mL) was stirred at room temperature for 5 min before
NaBH(OAc)3 (1.72 g, 8.12 mmol) was added in small portions over
5 min. The clear solution turned immediately cloudy and was left stirring
over nitrogen for 2 h. NaHCO3 (saturated solution, 100 mL) was added,
the organic phase was separated, and the aqueous phase was extracted
with CH2Cl2 (50 mL). The combined organic phase was washed with
NaHCO3 (2<80 mL) and brine (80 mL), dried (MgSO4), and was concen-
trated under reduced pressure to give a crude yellow oil. Purification by
flash column chromatography (15<2.5 cm, CH2Cl2!CH2Cl2/EtOH 3:1
yielded the title compound (2.54 g, 82%) as a colourless oil. 1H NMR
(300 MHz, CDCl3): d = 1.44 (s, 9H; Boc), 1.48 (s, 9H; Boc), 1.54 (m,
6H; C(CH3)2), 1.63 (m, 2H; NHCH2CH2CH2NHBoc), 2.65 (m, 1H;
NHCHCHaHbNH), 2.71 (m, 2H; NHCH2CH2CH2NHBoc), 2.88 (m, 1H;
NHCHCHaHbNH), 3.19 (m, 2H; NHCH2CH2CH2NHBoc), 3.78–
3.40 ppm (m, 3H; OCHaHb, OCH2CH);
13C NMR (56 MHz, D2O): d =
23.1, 24.3, 26.8, 27.6 (C(CH3)2), 28.4 (C(CH3)3), 29.7
(NHCH2CH2CH2NHBoc), 39.3 (NHCH2CH2CH2NHBoc), 47.7
(NHCH2CH2CH2NHBoc), 51.5 (CHCHaHbNH), 57.0, 57.2 (OCH2CH),
66.2 (OCH2), 79.0, 79.6, 80.2 (C(CH3)3), 93.4, 93.8 (C(CH3)2), 156.0 ppm
(NHC(O)OtBu); HRMS (FAB+ , NBA): m/z : calcd for C19H38N3O5:
388.2811, found 388.2815 [M+H]+ .
Fully deprotected triamine 5 : Compound 4 (2.32 g, 5.98 mmol) was stir-
red overnight at room temperature with aqueous HCl 6m/EtOH (1:1,
40 mL). The solvent was removed under reduced pressure. The residue
was repeatedly co-evaporated with water, dissolved in water (~20 mL)
and adjusted to pH 7 with DOWEX 1X-100-OH resin (~20 mL wet
resin). The resin was filtered off and the filtrate was evaporated under re-
duced pressure to give a white vitreous solid (quantitative yield). This
material was carried through without further purification. 1H NMR
(300 MHz, CDCl3): d = 2.17 (qt, J = 7.5 Hz, 2H; NHCH2CH2CH2NH),
3.14 (t, J = 7.5 Hz, 2H; NHCH2CH2CH2NH), 3.21 (td, J = 7.5, 2.4 Hz,
2H; NHCH2CH2CH2NH), 3.30 (dd, J = 13.4, 6.6 Hz, 1H; NHCH-
(CH2OH)CHaHbN), 3.41 (dd, J = 13.4, 5.4 Hz, 1H; NHCH-
(CH2OH)CHaHbN), 3.72 (m, 1H; NHCH(CH2OH)CH2N), 3.87 ppm (m,
2H; NHCH(CHaHbOH)CH2N); MS (EI
+): m/z : 148.15 [M+H]+; HRMS
(EI+): m/z : calcd for C6H18N3O: 148.1450, found 148.1450 [M+H]
+ .
Fully alkylated compound 6 : DIPEA (11.0 mL, 64.5 mmol), tert-butyl
bromoacetate (9.0 mL, 60.5 mmol), and KI (1.63 g, 9.80 mmol) were
added to compound 5 (3.12 g, 8.06 mmol) partially dissolved in DMF.
The solution turned yellow and was left stirring over a period of 64 h.
The solvent was evaporated under reduced pressure, giving rise to a
yellow and a white solid. The residue was taken into ethyl acetate
(200 mL) and the white solid was filtered off. The organic phase was
washed with NaHCO3 (sat. sol. , 2<100 mL) and brine (100 mL), and was
dried (MgSO4). The solvent was removed under reduced pressure leaving
behind a yellow oil. Purification by flash chromatography (19<2.5 cm)
with hexane!hexane/Ethyl acetate 1:1 yielded the title compound
(4.40 g, 76%) as a pale yellow oil. 1H NMR (300 MHz, CDCl3): d = 1.45
(s, 45H; C(CH3)3), 1.60 (m, 2H; NCH2CH2CH2N), 2.45–2.79 (m, 6H;
NCH(CHaHbOH)CH2NCH2CH2CH2N), 2.93 (m, 1H; NCHCH2N), 3.211
(d, J = 6.9 Hz, 1H; NCH(CHaHbOH)CH2N), 3.40 (s, 6H; acetate), 3.44
(s, 4H; acetate), 3.66 ppm (dd, J = 11.4, 4.8 Hz, 1H; NCH-
(CHaHbOH)CH2N);
13C NMR (56 MHz, CDCl3): d = 26.2
(NCH2CH2CH2N), 28.08 (C(CH3)3), 51.89, 52.59 (NCH2CH2CH2N), 53.6
(NCH2C(O)OtBu), 54.3 (NCHCH2N), 55.8 (NCH2C(O)OtBu), 56.1
(NCH2C(O)OtBu), 62.0 (NCH(CHaHbOH)CH2N), 62.3 (NCH-
(CHaHbOH)CH2N), 80.9, 81.0, 81.1 (C(CH3)3), 17.6, 171.8 ppm
(NCH2C(O)OtBu); HRMS (FAB
+ , NBA): m/z : calcd for C36H68N3O11:
718.4845, found 718.4854 [M+H]+ .
Fully deprotected palmitic ester conjugate 8 : Palmitic anhydride (2.29 g,
4.63 mmol), pyridine (1 mL, 12.5 mmol), and 4-dimethylaminopyridine
(28.6 mg, 0.234 mmol) were added to a solution of compound 6 (1.68 g,
2.34 mmol) in anhydrous CH2Cl2 (30 mL), and the reaction mixture was
stirred at room temperature under a nitrogen atmosphere. After 24 h the
reaction mixture was quenched with cold water. CH2Cl2 (70 mL) was
added to the mixture and the organic phase was separated and washed
with KHSO4 (2<100 mL), NaHCO3 (3<100 mL), and brine (1<100 mL);
dried (MgSO4); and concentrated under reduced pressure. The crude oil
obtained was purified by flash chromatography (20<2.5 cm) with petrole-
um ether 40–60!petroleum ether/ethyl acetate 1:1.5 to give the fully al-
kylated palmitic ester conjugate as an adduct with an extra molecule of
palmitic acid 7. 1H NMR (300 MHz, CDCl3): d = 0.89 (t, 6H; CH3), 1.27
(m, 48H; CH2 alkyl chain), 1.46 (s, 45H; tBu), 1.64 (m, 6H; overlapped
signals from OC(O)CH2CH2 and NCH2CH2CH2N), 2.33 (m, 4H), 2.65
(m, 5H), 2.85 (dd, J = 13.5 and 5.4 Hz, 1H; NCH(CH2O)CHaHbN), 3.11
(m, 1H; NCH), 3.28 (s, 2H; NCH2C(O)OtBu), 3.41 (s, 4H;
NCH2C(O)OtBu), 3.49 (s, 4H; NCH2C(O)OtBu), 4.12–4.24 ppm (m, 2H;
NCHCHaHbO); HRMS (ESI
+): m/z : calcd for C52H98N3O12: 956.7150,
found 956.7145 [M+H]+ . This material was carried through without fur-
ther purification.
Compound 7 was stirred overnight at room temperature with CH2Cl2/
TFA 3:1 (15 mL). The solvent was removed under reduced pressure, the
residue was re-dissolved in CH2Cl2 (20 mL), and the solvent was removed
under reduced pressure. This procedure was repeated several times and
the material was further dried under vacuum to give a white solid. Distil-
led water (100 mL) was added to this product and the resulting suspen-
sion was adjusted to pH 7 with a 0.1m aqueous solution of KOH. The
suspension was filtrated through a nylon membrane filter (0.22 mm). The
filtrate was concentrated under reduced pressure and the crude product
obtained was purified by flash chromatography on reversed-phase RP8
silica with gradient elution 100% H2O!100% EtOH. The relevant frac-
tions were pooled and the solvent was removed under reduced pressure
to afford the title compound as a white solid (0.76 g, 48% over two
steps). 1H NMR (300 MHz, D2O): d = 0.87 (t, 3H; CH3), 1.28 (m, 24H;
CH2 alkyl chain), 1.60 (m, 2H; OC(O)CH2CH2), 2.09 (m, 2H;
NCH2CH2CH2N), 2.43 (t, J = 7.2 Hz, 2H; OC(O)CH2), 3.0–3.40 (m, 6H;
overlapping signals from NCH(CH2OH)CHaHbNCH2CH2CH2N), 3.51 (s,
4H; acetate protons), 3.62 (m, 3H; overlapping signals from NCH-
(CH2OH)CH2N and central acetate protons), 3.77 (s, 4H; acetate pro-
tons), 4.26 ppm (m, 2H; NCH(CH2O)CH2N);
13C NMR(56 MHz, D2O):
d = 16.7 (CH3, alkyl chain), 23.7 (NCH2CH2CH2N), 25.4 (CH2 alkyl
chain), 27.3 (OC(O)CH2CH2), 31.6, 31.8, 32.0, 32.1, 32.2, 32.3, 32.3, 34.6
(CH2 alkyl chain), 36.6 (OC(O)CH2), 45.9, 54.0 (NCH(CH2OH)CH2N),
56.2, 56.5 (NCH2CH2CH2N), 57.4, 57.3–57.6 (cluster of signals from
NCH2COOH), 59.9 (NCH(CH2OC(O))CH2N), 60.1 (NCH2COOH), 64.2
(NCH(CH2OC(O))CH2N), 174.0 (C(O), ester), 176.2, 178.6, 179.0 ppm
(C(O), carboxylic acid); HRMS (ESI): m/z : calcd for C32H58N3O12:
676.4001, found 676.4015 [M+H]+ .
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